About
As of yet the MHRA don’t have a confirmed date for the next GMDP Symposium, however this is likely to be in 2025.
To ensure you stay up to date on future events, please sign up to receive their MHRA conferences email alerts.
As of yet the MHRA don’t have a confirmed date for the next GMDP Symposium, however this is likely to be in 2025.
To ensure you stay up to date on future events, please sign up to receive their MHRA conferences email alerts.
Cheryl joined the MHRA as a GDP inspector in 2005. Cheryl is a Chartered Chemist and spent many years working within industry as a research chemist during which time she filed a number of patents both European and Worldwide. She has extensive experience working within Project and Programme Management roles with responsibility for a wide range of projects spanning various scientific and engineering disciplines. As well a performing a full range of GDP inspections nationwide, Cheryl was the MHRA representative on the GDP drafting Group at the EMA. Since the current guidance has been implemented, Cheryl has been leading the project to raise awareness within the medicines supply chain that companies and sites not previously regulated are impacted by the change in legislation. She has a particular interest in compliance issues surrounding international trade and is active on a number of cross governmental working groups currently discussing these issues.
Peter is a part of the Senior GDP Inspectorate, having joined as an Inspector 8 years ago. Peter previously has worked in law enforcement roles and in a variety of pharmaceutical commercial, quality and operational functions prior to joining the MHRA. Peter currently is a member and former chair of the PIC/S GDP Expert Circle and regularly speaks at industry events.
Claire joined the team as a GDP inspector in late February 2022. Prior to this, she worked in various roles within the Agency, such as Enforcement and QIE (Quality, Improvement & Engagement), since joining in 2017.
Tanya is an Operations Manager and GDP Inspector and joined the MHRA in September 2019. Before joining the agency Tanya worked in the pharmaceutical industry for 13 years in various roles including senior roles in quality assurance.
Prior to joining the UK Medicines and Healthcare products Regulatory Agency in 2007 Chris graduated with an B.Sc.(Hons.) degree in chemistry and held a variety of roles in industry. Her work experience spans working in contract research as an analytical chemist, working within DEFRA as a chemist on a variety of research projects and within contract research as a GLP study director for both ecotoxicology and physical chemistry studies. Chris initially worked in the Good Laboratory Practice team at MHRA as an accredited then senior inspector and Operations Manager before transferring to a management role within GMP in 2014.
In her current role Chris is responsible for leadership of 5 teams of highly skilled inspectors performing statutory inspections globally to assess compliance with Good Manufacturing Practice, Good Distribution Practice and UK Blood Safety and Quality Regulations to ensure the safety of UK patients.
Chris is a specialist in laboratory-based science having in-depth knowledge of both the application of GLP principles in all types of testing facilities and of EU GMP in a QC testing environment. She is a subject matter expert for these activities within MHRA and has conducted over 300 inspections of UK facilities against GLP and GMP.
Chris has also worked on projects on a diverse range of topics including data integrity, inspection processes, business improvement and regulatory processes for cannabis based medicinal products.
Emanuela is a Senior GDP inspector. She joined the MHRA in May 2017 as part of the Process Licensing team. Emanuela joined the GDP Inspectorate in June 2019. She holds a degree in pharmacology.
Terry is a Senior Inspector within the GDP Inspectorate at the Medicines and Healthcare products Regulatory Agency (MHRA). He joined the Agency in 2009 having previously worked over 25 years in a variety of pharmaceutical industry technical and managerial roles within R&D and quality assurance.
John is Head of GDP Team 2 and GDP inspector within Healthcare Quality & Access Team part of The Medicines and Healthcare products Regulatory Agency (MHRA). He joined the Agency in 2020 having previously worked over 25 years in Logistics at Boots the Chemist and The Post Office in a variety of Supply Chain and Logistics Managerial roles.
Biography coming soon.
Chris joined The Medicines and Healthcare Products Regulatory Agency (MHRA) in 2020 as an inspector within the GDP Team. Chris started his career in academia gaining his PhD whilst studying structural biology and drug design. Following postgraduate studies in rare diseases he moved onto working in industry as both laboratory manager and Responsible Person on a WDA (H).
Lia is a GDP Inspector and joined the MHRA in February 2022. Before joining the Agency Lia worked in the pharmaceutical industry for over 15 years in various roles ranging from analytical chemist to senior roles in quality assurance.
Julio joined the MHRA as a GMDP inspector in 2021. Prior to joining the Agency, he worked in the pharmaceutical industry for approximately 20 years in positions which included R&D, Quality Control, Analytical Development, Validation, Stability and Quality Assurance.
Graham joined the MHRA as a GMDP Inspector in 2013 before becoming a GMDP Operations Manager in 2017. In 2019 he also became a Senior Inspector. Graham is a Mechanical Engineer (MEng) by training. Prior to joining the MHRA he spent eight years working in the pharmaceutical industry in the areas of human plasma fractionation and sterile product manufacturing; this included operational and managerial roles in Validation and Quality Assurance. Graham specialises in the inspection of sterile product manufacture as well as the collection, processing and supply of blood and blood components.
Biography coming soon.
Biography coming soon.
Ewan joined the MHRA as a GMP inspector in January 2013. Prior to joining the Agency, he worked in the Pharmaceutical industry for approximately 19 years in positions which included R&D, Scale-up, Process Validation, Outsourcing, Regulatory Affairs and Quality Assurance.
Biography coming soon.
Martine joined the MHRA as a GMDP inspector in 2014. Prior to joining the Agency, she worked in Operations and Quality within the pharmaceutical industry for approximately 20 years with wide experience across different senior Quality roles. Martine is eligible to act as a Qualified Person under the permanent provisions.
She has knowledge of a variety of dosage forms, as well as licencing, regulatory and GMP requirements for both Licenced and Investigational Medicinal Products. Martine is one of the SME’s for IMPs in the MHRA inspectorate and is also involved in Biological, ATMP and Radiopharmaceutical sites and processes.
Biography coming soon.
Biography coming soon.
Biography coming soon.